Profit Margin: Net Income as a portion of total sales revenue. Calculated as: Net Income / Total Revenues
Autolus Therapeutics PLC Sponsored ADR (AUTL) had Profit Margin of -2180.45% for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
$10.12M |
|
$-220.66M |
|
$11.39M |
|
$-1.27M |
|
$251.55M |
|
$-241.43M |
|
$22.29M |
|
$-219.13M |
|
$-219.13M |
|
$-220.66M |
|
$-220.66M |
|
$-220.66M |
|
$-220.66M |
|
$-241.43M |
|
$-233.71M |
|
255.16M |
|
255.16M |
|
$-0.86 |
|
$-0.86 |
|
| Balance Sheet Financials | |
$660.93M |
|
$49.55M |
|
$121.80M |
|
$782.73M |
|
$60.74M |
|
$49.63M |
|
$294.66M |
|
$355.40M |
|
$427.32M |
|
$414.95M |
|
$427.32M |
|
266.13M |
|
| Cash Flow Statement Financials | |
$-206.27M |
|
$-394.55M |
|
$589.55M |
|
$240.34M |
|
$228.81M |
|
$-11.53M |
|
$15.47M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
10.88 |
|
-- |
|
-- |
|
0.10 |
|
0.12 |
|
-12.52% |
|
-2385.63% |
|
-2385.63% |
|
-2309.39% |
|
-2165.36% |
|
|
Profit Margin |
-2180.45% |
$-228.35M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
2.75 |
|
-- |
|
-- |
|
-51.64% |
|
-53.18% |
|
-28.19% |
|
-46.26% |
|
$1.61 |
|
$-0.89 |
|
$-0.81 |
|